Sachiyo Hashi1, Ikuko Yano2, Mai Shibata3, Riki Matsumoto4, Akio Ikeda5, Atsushi Yonezawa6, Ryosuke Takahashi7, Kazuo Matsubara8 (1.Kyoto University Hospital, 2.Kobe University Hospital, 3.Kyoto University, 4.Kyoto University, 5.Kyoto University, 6.Kyoto University, 7.Kyoto University, 8.Kyoto University Hospital)
Session information
Oral
[O25-2] O25-2: CNS and miscellaneous
Mon. Sep 25, 2017 1:30 PM - 2:30 PM Room D (1F)
Chairs: Koichiro Tsuchiya, Japan / Yasuo Takeda, Japan
Robert Lovsletten Smith1, Tore Haslemo2, Kjersti Bjoentegaard3, Ole Andreassen4, Espen Molden5 (1.Diakonhjemmet Hospital, 2.Diakonhjemmet Hospital, 3.Diakonhjemmet Hospital, 4.NORMENT K.G. Jebsen Centre for Psychosis Research, 5.Diakonhjemmet Hospital)
Reinier van Hest1, Lisette Schutte2, Carina Stoof3, Frank Leebeek4, Marjon Cnossen5, Marieke Kruip6, Ron Mathot7 (1.Academic Medical Center Amsterdam, 2.Erasmus Medical Center Rotterdam, 3.Erasmus Medical Center Rotterdam, 4.Erasmus Medical Center Rotterdam, 5.Erasmus Medical Center Rotterdam, 6.Erasmus Medical Center Rotterdam, 7.Academic Medical Center Amsterdam)
Veronica Krogstad1, Alexandra Peric2, Ida Robertsen3, Philip Carlo Angeles4, Rune Sandbu5, Line Kristin Johnson6, Joran Hjelmesaeth7, Cecilia Karlsson8, Shalini Andersson9, Anders Asberg10, Tommy Andersson11, Hege Christensen12 (1.University of Oslo, 2.AstraZeneca Gothenburg, 3.University of Oslo, 4.The Morbid Obesity Center and Vestfold Hospital Trust, 5.The Morbid Obesity Center and Vestfold Hospital Trust, 6.The Morbid Obesity Center and Vestfold Hospital Trust, 7.The Morbid Obesity Center and Vestfold Hospital Trust, 8.AstraZeneca Gothenburg, 9.AstraZeneca Gothenburg, 10.University of Oslo, 11.AstraZeneca Gothenburg, 12.University of Oslo)